Literature DB >> 8431191

Measuring performance decrements in aviation personnel infected with the human immunodeficiency virus.

R L Mapou1, G G Kay, J R Rundell, L Temoshok.   

Abstract

There is controversy over whether cognitive impairment occurs in early human immunodeficiency virus (HIV) disease. When impairment is reported, findings are typically subclinical, affect only a minority, and their relationship to occupational functioning has not been established. Despite such findings, it has been recommended that HIV-seropositive pilots be disqualified from flying. This paper reviews research relevant to measuring performance decrements in HIV-infected aviators. Based upon current data, we conclude that although subtle neurobehavioral dysfunction may occur in some asymptomatic HIV-seropositive individuals, there is no research which has demonstrated associated decrements in aviation-related skills. Thus, it may be premature to recommend medical disqualification of all HIV-seropositive aviators. We propose, instead, that sensitive neurocognitive measures, incorporated into a comprehensive neurodiagnostic evaluation, could be used to evaluate asymptomatic HIV-seropositive aviators. Only those who are impaired on evaluation would be disqualified from flying. Concurrently, research investigating the relationship between abnormalities and aviation abilities would be conducted.

Entities:  

Mesh:

Year:  1993        PMID: 8431191

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  2 in total

1.  The US Military HIV Natural History Study: Informing Military HIV Care and Policy for Over 30 Years.

Authors:  Brian K Agan; Anuradha Ganesan; Morgan Byrne; Robert Deiss; Christina Schofield; Ryan C Maves; Jason Okulicz; Xiuping Chu; Thomas O'Bryan; Tahaniyat Lalani; Karl Kronmann; Tomas Ferguson; Merlin L Robb; Timothy J Whitman; Timothy H Burgess; Nelson Michael; Edmund Tramont
Journal:  Mil Med       Date:  2019-11-01       Impact factor: 1.437

2.  Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons.

Authors:  Nancy F Crum-Cianflone; David J Moore; Scott Letendre; Mollie Poehlman Roediger; Lynn Eberly; Amy Weintrob; Anuradha Ganesan; Erica Johnson; Raechel Del Rosario; Brian K Agan; Braden R Hale
Journal:  Neurology       Date:  2013-01-09       Impact factor: 9.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.